Stationary entanglement of a levitated oscillator with an optical field

October 1, 2026| Source: Science

Stationary entanglement between the motion of macroscopic objects and light is a long-standing goal of quantum optomechanics, with implications for both fundamental tests of quantum physics and emerging quantum technologies. We report the generation of quantum entanglement between the center-of-mass motion of a nanosphere levitated in an optical tweezer inside an optical cavity and the electromagnetic field. Using heterodyne detection, we reconstructed the full set of optomechanical correlations and observed a violation of separability bounds between the mechanical motion and a propagating optical mode, demonstrating the distribution of nonclassical correlations beyond the interaction region. The entanglement was generated at room temperature and remained robust over a broad range of parameters. Our results establish levitated optomechanical systems as a platform for continuous-variable quantum communication and for tests of macroscopic quantum physics.

Read the original source →

Convergent innovation of (crypto)vivipary via asymmetric dismantling of seed desiccation and dormancy machinery.

Cryptovivipary and vivipary, referred to as (crypto)vivipary, occur across multiple angiosperm lineages and enable embryos to continue developing before dispersal. Yet, this trait raises a fundamental question: how are seed-specific abscisic acid (ABA) responses modulated to support continuous embryonic growth without compromising ABA-dependent vegetative stress tolerance? Here, integrating phylogenomic analyses of independently evolved (crypto)viviparous lineages with spatiotemporal transcripto

Physical/TechOctober 6, 2026

Cassiterite U-Pb geochronology: A framework for tin provenance in the Bronze Age world.

The origin of Bronze Age tin is one of the most compelling mysteries in global archaeology. A number of studies were carried out to identify fingerprints to determine tin sources, but all failed to suit the contexts of Bronze Age China. This study provides the first comprehensive provenance analysis of the tin ore utilized during the Shang dynasty of China. Using U-Pb dating analysis on cassiterite grains surviving in various contexts including primary smelting site, metal resource hoard, and br

Physical/TechOctober 6, 2026

Nuclear cGAS inhibits stimulation-induced inflammatory gene transcription via HDAC1.

Cyclic GMP-AMP synthase (cGAS) is a cytosolic DNA sensor that detects aberrant DNA and activates the STING-dependent innate immune response. Although cGAS is predominantly localized in the nucleus under physiological conditions, its nuclear function remains incompletely understood. Here, we identify nuclear cGAS as a transcriptional repressor that restrains inflammatory gene expression independently of STING signaling. Using macrophages challenged with lipopolysaccharide (LPS), we found that cGA

Physical/TechOctober 6, 2026

Dynamic tRNA modification programs align codon usage with growth-phase-specific gene expression in Pseudomonas aeruginosa .

Post-transcriptional transfer RNA (tRNA) modifications dynamically regulate translational capacity, yet whether the tRNA epitranscriptome is temporally coordinated with gene expression programs during bacterial growth remains unknown. Here, we combine time-resolved nanopore tRNA sequencing, liquid chromatography-tandem mass spectrometry modification profiling, transcriptomics, and proteomics across the Pseudomonas aeruginosa PA14 growth cycle to show that tRNA-modifying enzymes, the correspondin

Physical/TechOctober 1, 2026

Giredestrant plus Everolimus in Advanced Breast Cancer.

Giredestrant and everolimus target the estrogen receptor (ER) pathway and the phosphatidylinositol 3-kinase (PI3K)-protein kinase B (AKT)-mammalian target of rapamycin (mTOR) pathway, respectively, which are implicated in endocrine-therapy resistance. In this phase 3, open-label, randomized trial, we enrolled patients with ER-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer who had disease progression or recurrence after receipt of a